Fibroadenoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Fibroadenoma}} | {{Fibroadenoma}} | ||
{{CMG}} {{AE}} {{HL}} | |||
==Overview== | |||
==Epidemiology and Demographics== | |||
===Prevelance=== | |||
===Incidence=== | |||
===Age=== | |||
===Gender=== | |||
===Race=== | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 19:00, 29 January 2016
|
Fibroadenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma epidemiology and demographics |
|
Risk calculators and risk factors for Fibroadenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]